EU Commission Approves Simplified COVID-19 Vaccine Schedule for Young Children

The European Commission has updated the authorization for the Pfizer-BioNTech COVID-19 vaccine for children aged 6 months to 4 years. This change aims to simplify the vaccination process for families and healthcare providers across the EU and associated countries. The decision follows a safety data review, affirming a positive benefit-risk profile for this pediatric group.